Abstract
Triazoloacridinones (TA) are a class of antitumor agents including a new compound C-1305 now in preclinical trials. In this study, the ability of triazoloacridinones to DNA minor groove binding and relevance to biological activity was investigated, using fluorochrome displacement method. From selected seven triazoloacridinone derivatives, differing in chemical structures, as well as in cytotoxic and antitumour activities only four of them showed C50 parameters (stronger DNA-binders in the minor groove). Weak or lack of correlation between minor groove binding and cytotoxic activities, suggested that these modes of interaction do not play a major role in the mechanism of biological action of TA.
Keywords: Triazoloacridinones, Antitumor compounds, Minor groove binding, Intercalation, Mechanism of biological action
Letters in Drug Design & Discovery
Title: Is DNA Minor Groove Binding Crucial for Biological Activity of Triazoloacridinones with Cytotoxic and Antitumour Properties?
Volume: 6 Issue: 4
Author(s): Marcin Koba, Katarzyna Koba and Tomasz Baczek
Affiliation:
Keywords: Triazoloacridinones, Antitumor compounds, Minor groove binding, Intercalation, Mechanism of biological action
Abstract: Triazoloacridinones (TA) are a class of antitumor agents including a new compound C-1305 now in preclinical trials. In this study, the ability of triazoloacridinones to DNA minor groove binding and relevance to biological activity was investigated, using fluorochrome displacement method. From selected seven triazoloacridinone derivatives, differing in chemical structures, as well as in cytotoxic and antitumour activities only four of them showed C50 parameters (stronger DNA-binders in the minor groove). Weak or lack of correlation between minor groove binding and cytotoxic activities, suggested that these modes of interaction do not play a major role in the mechanism of biological action of TA.
Export Options
About this article
Cite this article as:
Koba Marcin, Koba Katarzyna and Baczek Tomasz, Is DNA Minor Groove Binding Crucial for Biological Activity of Triazoloacridinones with Cytotoxic and Antitumour Properties?, Letters in Drug Design & Discovery 2009; 6 (4) . https://dx.doi.org/10.2174/157018009788452465
DOI https://dx.doi.org/10.2174/157018009788452465 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
New Use for Old Drugs? Prospective Targets of Chloroquines in Cancer Therapy
Current Drug Targets Targeted Therapy for Advanced Renal Cell Cancer: Cytokines and Beyond
Current Pharmaceutical Design Metastatic Cancer Stem Cells: New Molecular Targets for Cancer Therapy
Current Pharmaceutical Biotechnology Nucleoside Transporter Proteins
Current Vascular Pharmacology Bcl-2 Inhibitors: Emerging Drugs in Cancer Therapy
Current Medicinal Chemistry A Medicinal Chemist’s Perspective Towards Structure Activity Relationship of Heterocycle Based Anticancer Agents
Current Topics in Medicinal Chemistry Thermodynamics and Electro-Biologic Prospects for Therapies to Intervene in Cancer Progression
Current Cancer Therapy Reviews Novel and Emerging Drugs for Acute Myeloid Leukemia: Pharmacology and Therapeutic Activity
Current Medicinal Chemistry Role of Stem Cells in Normal Liver and Cancer
Anti-Cancer Agents in Medicinal Chemistry Targeting EZH2 for Cancer Therapy: Progress and Perspective
Current Protein & Peptide Science Chromosomal Abnormalities, Cancer and Mouse Models The Critical Role of Translocation-Associated Genes in Human Cancer
Current Genomics Isolation of a New Sesquiterpene Lactone From Vernonia Zeylanica (L) Less and its Anti-Proliferative Effects in Breast Cancer Cell Lines
Anti-Cancer Agents in Medicinal Chemistry Antioxidant, Pro-Oxidant and Other Biological Activities of Sesquiterpenes
Current Topics in Medicinal Chemistry Retinoic Acid and Iron Metabolism: A Step Towards Design of a Novel Antitubercular Drug
Current Pharmaceutical Biotechnology Serum Proteomics in the Diagnosis and Treatment of Haematological Malignancies
Current Proteomics Adeno-Associated Virus-Mediated Gene Transfer in Hematopoietic Stem/Progenitor Cells as a Therapeutic Tool
Current Gene Therapy Overview of Tumor-Associated Antigens (TAAs) as Potential Therapeutic Targets for Prostate Cancer Therapy
Current Cancer Therapy Reviews New Directions in Targeting Protein Kinases: Focusing Upon True Allosteric and Bivalent Inhibitors
Current Pharmaceutical Design From Amino Acids to Proteins as Targets for Metal-based Drugs
Current Drug Metabolism An Overview of Innovations in Analysis and Beneficial Health Effects of Wine Polyphenols
Mini-Reviews in Medicinal Chemistry